Hooman Kamel (@hoomankamel) 's Twitter Profile
Hooman Kamel

@hoomankamel

Vice Chair for Research @WCMCNeurology

ID: 361340466

linkhttps://brainandmind.weill.cornell.edu/clinical-translational-neuroscience-unit calendar_today24-08-2011 16:52:06

1,1K Tweet

1,1K Followers

119 Following

Thanh Lam "Lance" Tran (@lance_tran_) 's Twitter Profile Photo

Debate continues w Hooman Kamel 's con position vs LAAO. He cites meta-analysis with a trend of ischemic events (don't look at the composite primary) favoring OAC. Also, criticizes limited historical data + sample sizes relative to AC data. & he shows off his car!! 😆🚗#ISC23

Debate continues w <a href="/hoomankamel/">Hooman Kamel</a> 's con position vs LAAO. He cites meta-analysis with a trend of ischemic events (don't look at the composite primary) favoring OAC. Also, criticizes limited historical data + sample sizes relative to AC data. &amp; he shows off his car!! 😆🚗#ISC23
Hooman Kamel (@hoomankamel) 's Twitter Profile Photo

Hopefully this will be helpful for stroke researchers working with administrative data! 👇 Validation of the ICD-10 Code for the National Institutes of Health Stroke Scale Score ahajournals.org/doi/10.1161/CI… Circ: CQO Stroke AHA/ASA Weill Cornell Neurology

Continuum: Lifelong Learning in Neurology (@continuumaan) 's Twitter Profile Photo

Sneak peek at the #Cerebrovascular Disease issue, guest edited by Dr. Hooman Kamel (Hooman Kamel), publishing April 11 at ContinuumJournal.com. Weill Cornell Medicine #stroke #neurology #MedEd #NeuroTwitter

Sneak peek at the #Cerebrovascular Disease issue, guest edited by Dr. Hooman Kamel (<a href="/hoomankamel/">Hooman Kamel</a>), publishing April 11 at ContinuumJournal.com. <a href="/WeillCornell/">Weill Cornell Medicine</a>  #stroke #neurology #MedEd #NeuroTwitter
Lyell Jones MD (@lyellj) 's Twitter Profile Photo

It’s official! The latest Continuum issue on Cerebrovascular Disease is online, and shipping! 🧠Latest on treatment and prevention of acute ischemic stroke 🧠Diagnosis and management of CV disorders (CVT, dissection, AVMs) 🧠Pediatric stroke Link: journals.lww.com/continuum/page…

It’s official! The latest Continuum issue on Cerebrovascular Disease is online, and shipping!

🧠Latest on treatment and prevention of acute ischemic stroke
🧠Diagnosis and management of CV disorders (CVT, dissection, AVMs)
🧠Pediatric stroke 

Link: journals.lww.com/continuum/page…
Hooman Kamel (@hoomankamel) 's Twitter Profile Photo

Richard Bernstein introduces an awesome new term — SCAFDAS, subclinical AF detected after stroke — in his debate presentation about loop recorders after stroke #ISC24 Stroke AHA/ASA

Richard Bernstein introduces an awesome new term — SCAFDAS, subclinical AF detected after stroke — in his debate presentation about loop recorders after stroke #ISC24 <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a>
JAMA (@jama_current) 's Twitter Profile Photo

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not significantly reduce recurrent stroke risk compared with aspirin. #ISC24 ja.ma/3Us1vde

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not significantly reduce recurrent stroke risk compared with aspirin. 

 #ISC24

ja.ma/3Us1vde
Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo

Phase 3 clinical trial finds that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with atrial cardiopathy. Findings from team led by Weill Cornell Neurology may help inform treatment for stroke patients. bit.ly/3SLwwXh

Phase 3 clinical trial finds that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with atrial cardiopathy. 

Findings from team led by <a href="/WCMCNeurology/">Weill Cornell Neurology</a> may help inform treatment for stroke patients. 

bit.ly/3SLwwXh
Gunnar Henrik Heine (@gunnar_heine) 's Twitter Profile Photo

DOACs are no panacea in secondary stroke prevention: Apixaban is not better than ASS for preventing recurrence after Cryptogenic Stroke in patients with atrial cardiopathy in Hooman Kamel ‘s ARCADIA trial (great editorial by Greg Marcus). jamanetwork.com/journals/jama/…

Hooman Kamel (@hoomankamel) 's Twitter Profile Photo

Steven Warach presents the phase 2 START trial of timing of anticoagulation after AF related stroke. Results supportive of early DOAC start among patients with moderately severe stroke #isc24 ##ISC2024 Stroke AHA/ASA AHA Science

Steven Warach presents the phase 2 START trial of timing of anticoagulation after AF related stroke. Results supportive of early DOAC start among patients with moderately severe stroke #isc24 ##ISC2024 <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a> <a href="/AHAScience/">AHA Science</a>
Greg Marcus (@gregorymmarcus) 's Twitter Profile Photo

🙏Congrats Hooman Kamel + team on a novel + high-quality #RCT tackling: might #Afib be an epiphenomenon of an atrial myopathy as the true cause of thromboemboli? #ARCADIA was negative, BUT, as per our editorial, don't close the 📖yet! UCSF Cardiology JAMA

Kirsten Bibbins-Domingo (@kbibbinsdomingo) 's Twitter Profile Photo

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA RCT Hooman Kamel Weill Cornell Medicine Weill Cornell Neurology & colleagues jamanetwork.com/journals/jama/… …our Top Viewed this week at JAMA

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy:  The ARCADIA RCT <a href="/hoomankamel/">Hooman Kamel</a> <a href="/WeillCornell/">Weill Cornell Medicine</a>  <a href="/WCMCNeurology/">Weill Cornell Neurology</a> &amp; colleagues jamanetwork.com/journals/jama/…

…our Top Viewed this week at JAMA
John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

I don't expect as many clicks. Positive stories always trail negative stories. But it was fun writing about a great story of science done well on Sensible Medicine Congrats Hooman Kamel et al sensible-med.com/p/the-study-of…